DMT210 Topical Gel in the Treatment of Mild to Moderate Atopic Dermatitis
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 12 Jun 2017
At a glance
- Drugs DMT 200 (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors Dermata Therapeutics
- 07 Jun 2017 Planned End Date changed from 1 Mar 2017 to 1 Aug 2017.
- 07 Jun 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Aug 2017.
- 07 Jun 2017 Status changed from recruiting to active, no longer recruiting.